A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Clinical trial NCT05438706 · UNKNOWN
Trial details
- NCT number
- NCT05438706
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-10
- Primary completion
- 2023-11-10
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.